Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

Thank You!

Your message has been sent.

Oops, message not sent.

Please make sure fields are complete.

News

So Far 70 Registrations for Virtual Dialogue 2: March 20 at 1:00pm EST / New York Time


The Virtual Dialogue is scheduled for Saturday, March 20 at 1:00pm (Eastern Standard Time / New York). Registration for the Virtual Dialogue is still open but we are excited to share that as of today, we have 70 registrations from 10 different…

Read Article

The Dolphins Challenge Cancer event April 10, 2021 (virtual or in-person)


Support Me Howdy! The Dolphins Challenge Cancer event will take place on April 10, 2021. The DCC is a collective community movement to raise money in support of much needed Sarcoma cancer research. Consider…

Read Article

Virtual Dialogue 2: Innovations in Diagnosing and Treating Chondrosarcoma: March 20, 1:00PM EST


The registration is now open for the Chondrosarcoma Foundation’s Second International Virtual Dialogue. It is scheduled for Saturday, March 20, 2021 from 1:00pm – 2:30pm (EST/ New York time) on Zoom. Please register at…

Read Article

Registration for Cancer Cell Virtual Symposium February 8-11


Webinar Series Global Cell Therapy Virtual Symposium The journey from discovery to therapy begins with a single cell The path from research to effective cancer immune cell therapies requires innovative approaches to match the challenges we face….

Read Article

Chondrosarcoma Awareness Day is One Week Away.


One week from today is Chondrosarcoma Awareness Day. Thank you for going on our web site and signing on to support our petition for Chondrosarcoma Research and Clinical Trials. The Chondrosarcoma Foundation is initiating an international public…

Read Article

A medication to treat Soft Tissue Sarcomas gets FDA approval


Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS) Immunicum AB (publ; IMMU.ST) announced today that it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug…

Read Article

A clinical trial for treating Metastatic Convention Chondrosarcoma


Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in…

Read Article

Chondrosarcoma Awareness Day is in 11 days


We are 11 days from Chondrosarcoma Awareness Day. If you have not already done this, we are counting on you to do the following: 1. Get the Word Out. Join us in our efforts to educate the public about Chondrosarcoma, a rare bone and soft tissue…

Read Article

Contact Information


If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

Send a Message